Skip to main content
. 2018 Nov 30;1(7):e185239. doi: 10.1001/jamanetworkopen.2018.5239

Figure 1. Outcomes for the Efficacy End Points.

Figure 1.

Outcomes for the primary efficacy end point (composite of cardiovascular death, myocardial infarction, and ischemic stroke) (A), cardiovascular death (B), myocardial infarction (C), and ischemic stroke (D). CAD indicates coronary artery disease; CVD, cerebrovascular disease; and PAD, peripheral artery disease. For all panels P < .001.